Hypoxia induces macrophage tnfa expression via cyclooxygenase and prostaglandin E2 in vivo by Lewis, A. & Elks, P.M.
ORIGINAL RESEARCH
published: 27 September 2019
doi: 10.3389/fimmu.2019.02321
Frontiers in Immunology | www.frontiersin.org 1 September 2019 | Volume 10 | Article 2321
Edited by:
Alexandre Corthay,
Oslo University Hospital, Norway
Reviewed by:
Andreas Weigert,
Goethe University Frankfurt, Germany
Susan Frances Fitzpatrick,
University College Dublin, Ireland
Julián Aragones Lopez,
Autonomous University of
Madrid, Spain
*Correspondence:
Philip M. Elks
p.elks@sheffield.ac.uk
Specialty section:
This article was submitted to
Molecular Innate Immunity,
a section of the journal
Frontiers in Immunology
Received: 17 May 2019
Accepted: 13 September 2019
Published: 27 September 2019
Citation:
Lewis A and Elks PM (2019) Hypoxia
Induces Macrophage tnfa Expression
via Cyclooxygenase and Prostaglandin
E2 in vivo. Front. Immunol. 10:2321.
doi: 10.3389/fimmu.2019.02321
Hypoxia Induces Macrophage tnfa
Expression via Cyclooxygenase and
Prostaglandin E2 in vivo
Amy Lewis and Philip M. Elks*
The Bateson Centre and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield,
United Kingdom
Macrophage phenotypes are poorly characterized in disease systems in vivo. Appropriate
macrophage activation requires complex coordination of local microenvironmental
cues and cytokine signaling. If the molecular mechanisms underpinning macrophage
activation were better understood, macrophages could be pharmacologically tuned
during disease situations. Here, using zebrafish tnfa:GFP transgenic lines as in vivo
readouts, we show that physiological hypoxia and stabilization of Hif-1α promotes
macrophage tnfa expression. We demonstrate a new mechanism of Hif-1α-induced
macrophage tnfa expression via a cyclooxygenase/prostaglandin E2 axis. These findings
uncover a macrophage HIF/COX/TNF axis that links microenvironmental cues to
macrophage phenotype, with important implications during inflammation, infection,
and cancer, where hypoxia is a common microenvironmental feature and where
cyclooxygenase and TNF are major mechanistic players.
Keywords: hypoxia, TNF–tumour necrosis factor, COX–cyclooxygenase, zebrafish, prostaglandin, macrophage, in
vivo, HIF–hypoxia inducible factor
INTRODUCTION
Innate immune activation during homeostasis and disease are tightly regulated, in part by the
coordination of microenvironmental cues and cytokine signaling. Macrophages are important
innate immune cells in disease and their activation status, commonly termed polarization, is
especially important during the response to injury and infection. Mammalian macrophages have
been classified into two broad polarization states: M1 (or classically activated) andM2 (alternatively
activated) (1, 2). M1 macrophages are highly antimicrobial and can phagocytose and efficiently kill
bacteria. M2 macrophages are central players in tissue healing and restoration of homeostasis post
injury/infection (3, 4). M1/M2 polarization states have largely been determined in vitro by addition
of exogenous factors, e.g., cytokines, to the growth media, however the complex regulation of the
diverse macrophage phenotypes observed in vivo remains poorly understood. It is only in whole
organism in vivomodels, where tissues remain intact, that microenvironmental cues of macrophage
activation can be fully investigated.
Leukocytes, including macrophages and neutrophils, are exquisitely sensitive to tissue hypoxia,
a signature of many disease microenvironments (e.g., in inflammatory diseases, infections, and
cancers) due to lack of local blood supply and a high turnover of local oxygen by pathogens
(5, 6). Tissue hypoxia can polarize macrophages, via stabilization of the Hypoxia Inducible Factor
(HIF)-1α transcription factor (7). HIF-1α is a master transcriptional regulator of the cellular
response to hypoxia (8) and has been shown to have activating effects on macrophages in vitro,
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increasing their pro-inflammatory cytokine profile and
bactericidal capabilities, yet the molecular mechanisms behind
these observations are not well-understood in vivo (6).
Eicosanoids are lipid signaling molecules and important
pro-inflammatory mediators during homeostasis and disease
(9, 10). For example, tissue hypoxia increases cyclooxygenase
(COX)/prostaglandin E2 (PGE2) production in epithelial cells
in cancer models (11–13). Recent evidence indicates that
hypoxia-induced tumor necrosis factor alpha (TNF) expression
in osteoblasts (bone producing cells) is mediated through
cyclooxygenase enzymes by an, as yet, unknown mechanism
(14). This HIF/COX/TNF axis has not, to date, been observed
in macrophages, and could be a potential novel pathway
to macrophage activation in diseases where hypoxia is a
microenvironmental factor.
Here, we investigated the regulation of expression of the
important, primarily pro-inflammatory, cytokine tnfa by Hif-
1α stabilization in vivo using optically transparent zebrafish
larvae. We demonstrate that genetic, pharmacological, and
hypoxia-mediated Hif-1α stabilization upregulated macrophage
tnfa. We utilize well-characterized, non-invasive, zebrafish
models of inflammation and infection to show that Hif-1α-
mediated tnfa acts via an alternative, cyclooxygenase dependent
mechanism, that differs from better understood DAMP/PAMP
mediated pathways that are cyclooxygenase independent (15,
16). We show that the Hif-1α-mediated tnfa acts via active
PGE2. Furthermore, this new macrophage HIF/COX/TNF axis
is found in primary human macrophages. These findings
have important implications in inflammation, infection, and
cancer biology where macrophage phenotypes are influenced by
microenvironmental hypoxia, and where HIF, COX, and TNF are
major mechanistic players.
MATERIALS AND METHODS
Zebrafish
Zebrafish were raised and maintained on a 14:10 h light/dark
cycle at 28◦C, according to standard protocols (17), in
UK Home Office approved facilities at The Bateson Center
aquaria at the University of Sheffield. Strains used were Nacre
(wildtype), TgBAC(tnfa:GFP)pd1028 (Source: Bagnat lab, Duke
University, USA), Tg(tnfa:eGFP-F)ump5Tg:Tg(mpeg1:mCherry-
F)ump2Tg (Source: Lutfalla Lab, Montpellier University, France),
Tg(mpeg1:mCherryCAAX)sh378 (Source: University of Sheffield),
Tg(lyz:Ds-RED2)nz50 (Source: Hall Lab, University of Auckland,
New Zealand), TgBAC(il-1β:eGFP)sh445 (Source: University
Abbreviations: LOX, lipoxygenase; BLTR, leukotriene receptor; COX,
cyclooxygenase; DAMP, damage associated molecular pattern; DMOG,
dimethyloxaloylglycine; DMSO, dimethyl sulfoxide; Dpf, day post-fertilization;
Dpi, day post-infection; FBS, fetal bovine serum; GFP, green fluorescent protein;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HIF, hypoxia
inducible factor; hMDM, human monocyte derived macrophage; Hpf, hour
post-fertilization; Hpi, hour post-infection; Hpw, hour post-wound; HRE, HIF
responsive element; IL, Interleukin; Mm, Mycobacterium marinum; NFκB,
nuclear factor kappa-light-chain-enhancer of activated B cells; PAMP, pathogen
associated molecular pattern; PGE2, Prostaglandin E2; PMBC, peripheral blood
mononuclear cell; TLR, toll-like receptor; TNF, tumor necrosis factor.
of Sheffield), and Tg(phd3:EGFP)i144 (Source: University of
Sheffield) (18–22).
Tailfin Injury
Inflammation was induced in zebrafish embryos by tail
transection at 2 days post-fertilization (dpf). Larvae were
anesthetized and the tailfin was transected using a sterile scalpel
blade (23). Larvae were imaged by confocal microscopy at
16 h post-wounding (hpw) on a Leica TCS-SPE confocal on
an inverted Leica DMi8 base and imaged using 20× or 40×
objective lenses.
Mycobacterium marinum
Mycobacterium marinum (Mm) M (ATCC #BAA-535),
containing a psMT3-mCherry or psMT3 mCrimson vector
were used (24). Injection inoculum was prepared from an
overnight liquid culture in the log-phase of growth resuspended
in 2% polyvinylpyrrolidone40 (PVP40) solution (CalBiochem,
CAS 9003-39-8) (25). One hundred or one hundred and fifty
colony forming units (CFU) were injected into the caudal vein at
28–30 h post-fertilization (hpf) (26).
Confocal Microscopy of Transgenic Larvae
Larvae were mounted in 0.8–1% low melting point agarose
(Sigma-Aldrich, A9414) and imaged on a Leica TCS-SPE
confocal on an inverted Leica DMi8 base and imaged using 20×
or 40× objective lenses.
For quantification purposes acquisition settings and area of
imaging were kept the same across groups. Corrected total
cell fluorescence was calculated for each cell using Image J by
drawing around the cell and correcting for background levels of
staining (27, 28).
RNA Injections
Embryos were injected with dominant hif-1αb (ZFIN: hif1ab)
variant RNA at the one cell stage as previously described
(23). hif-1α variants used were dominant active (DA) that is a
constitutively stable Hif-1α and dominant negative (DN) hif-1α
that cannot signal due to lack of transactivation domain. Phenol
red (PR) (Sigma-Aldrich, P0290) was used as a vehicle control.
Bacterial Pixel Count
Mm mCherry infected zebrafish larvae were imaged at 4 days
post-fertilization (dpi) on an inverted Leica DMi8 with a 2.5×
objective lens. Brightfield and fluorescent images were captured
using a Hammamatsu OrcaV4 camera. Bacterial burden was
assessed using dedicated pixel counting software as previously
described (29).
Pathway Inhibitors
Unless otherwise stated, embryos were treated from 4 h pre-
Mm infection to 24 h post-infection (hpi) by addition to the
embryo water in six well plates and dimethyl sulfoxide (DMSO,
Sigma-Aldrich, D8418), was used as a negative solvent control.
The pan hydroxylase inhibitor, DMOG (dimethyloxaloylglycine,
Enzo Life Sciences, BML-EI347-0010), was used at a 100µM
concentration by incubation in E3 embryo media (23). The
selective PHD inhibitors JNJ-402041935 (Cayman Chemicals,
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FIGURE 1 | Macrophage tnfa:GFP is upregulated by injury, Mm infection and Hif-1α stabilization. (A) Confocal micrographs of 3 days post-fertilization larvae with or
without tailfin wound (16 hpw) at the tailfin site. tnfa expression was detected using the TgBAC(tnfa:GFP)pd1028 transgenic line. Macrophages are shown in red using
a Tg(mpeg1:mCherryCAAX)sh378 line. The white arrowhead indicates the presence of a tnfa:GFP negative, mpeg:mCherry positive macrophage in the tailfin of a
non-wounded control. Asterisk indicates a neuromast that is fluorescent in all channels as a marker of position. Representative images of three independent
experiments with 20–30 larvae per group per experiment. (B) Confocal micrographs of 1 dpi Mm mCrimson infected larvae, prior to granuloma formation (left panels),
and 4 dpi, early granuloma (right panels) stages of infection using the TgBAC(tnfa:GFP)pd1028 line. Representative images of three independent experiments with
20–30 larvae per group per experiment. (C) Confocal micrographs of 1 day post-infection (dpi) with Mm mCrimson at the caudal vein region of infection in the
TgBAC(tnfa:GFP)pd1028 line. Macrophages are shown in red using a Tg(mpeg1:mCherryCAAX)sh378 line. Mm in right panels with PVP control in left panels.
(Continued)
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FIGURE 1 | a Dotted lines indicate the yolk extension of the larvae where there is non-specific fluorescence. Representative images of three independent experiments
with 20–30 larvae per group per experiment. (D) Confocal micrographs of 2 dpf larvae in the caudal vein region in the TgBAC(tnfa:GFP)pd1028 line. Macrophages are
shown in red using a Tg(mpeg1:mCherryCAAX)sh378 line. Larvae were injected at the 1 cell stage with dominant active (DA) Hif-1α or phenol red (PR) control.
Representative images of three independent experiments with 20–30 larvae per group per experiment. (E) Confocal micrographs of 2 dpf zebrafish imaged around the
caudal vein region in the TgBAC(tnfa:GFP)pd1028 line. Larvae were injected at the 1 cell stage with dominant negative (DN) or dominant active (DA) Hif-1α or phenol
red (PR) control. (F) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (E). Mean ± SEM, n = 66 cells from 12 embryos accumulated from three
independent experiments and corresponds to images in (E). P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, one way ANOVA with Bonferonni post-test
adjustment. (G) Confocal micrographs of 2 dpf TgBAC(tnfa:GFP)pd1028 larvae treated with the PHD inhibitor FG4592 or a DMSO solvent control. Graph shows
corrected fluorescence intensity levels of tnfa:GFP. Mean ± SEM, n = 54 cells from nine embryos accumulated from three independent experiments. P-values shown
are: *P < 0.05, **P < 0.01, and ***P < 0.001, unpaired, two-tailed t-test. (H) Confocal micrographs of 2 dpf TgBAC(tnfa:GFP)pd1028 larvae treated with the PHD
inhibitor FG4592 or a DMSO solvent control. Larvae were injected at the 1 cell stage with dominant negative (DN) Hif-1α or phenol red (PR) control. (I) Corrected
fluorescence intensity levels of tnfa:GFP in larvae in (H). Mean ± SEM, n = 60 cells from 10 embryos accumulated from three independent experiments. P-values
shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment. (J) Confocal micrographs of 2 dpf
TgBAC(tnfa:GFP)pd1028 larvae incubated in room normoxia or 5% oxygen (hypoxia) for 6 h between 32 and 38 hpf. Graph shows corrected fluorescence intensity
levels of tnfa:GFP. Mean ± SEM, n = 72 cells from 12 embryos accumulated from three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and
***P < 0.001, unpaired, two-tailed t-test.
14316) and FG-4592 (Selleckchem, FG-34595) were used at
100 and 5µM, respectively (30, 31). The selective inhibitor
of COX-1, SC-560 (Cayman Chemical, 70340), was used at
30µM and the selective inhibitor of COX-2, NS-398 (Cayman
Chemical, 70590), was used at 15µM by incubation in E3
embryo media (32). The 15-LOX inhibitor PD146176 (Tocris,
2850) was microinjected (1 nl of 40 nM) at 1 h post-infection
(hpi) (33). The leukotriene B4 receptor 1 (BLTR1) inhibitor, U-
75302 (Abcam, ab141736), was used at 30mM by incubation
in E3 embryo media (33) together with the BLTR2 inhibitor,
LY255283 (Abcam, ab144472), which was used at 1mM (34).
Exogenous prostaglandin E2 (Cayman Chemical, 14010) and 15-
keto-prostaglandin E2 (Cayman Chemical, 14720) were added
by incubation in E3 at a concentration of 1µM (35). The EP4
antagonist AH23848 (Cayman Chemical, 19023) was used at
1 µM (36).
Hypoxia Hood
Embryos were incubated in 5% oxygen (with 5% carbon dioxide)
in a hypoxia hood (Baker-Ruskinn Sci-tive UM-027) from 32 hpi
for 6 h and were imaged at 2 dpf. Embryos from the same clutch
kept in incubated normoxic room air were used as controls (37).
Human Cells
Peripheral blood mononuclear cells (PBMC) were isolated
by Ficoll-Paque PLUS (GE Healthcare, GE17-1440-03) density
centrifugation of whole blood from healthy donors (National
Research Ethics Service reference 07/Q2305/7). PBMC were
seeded in RMPI 1640 media (Gibco, 11875-093) containing 2
mmol/L L-glutamine (Lonza, BE17-605F) and 10% newborn calf
serum (Gibco, 26010074). Cells were cultured in 5% CO2 at
37◦C for 14 days in RPMI 1640 supplemented with 2 mmol/L
L-glutamine and 10% heat-inactivated fetal bovine serum (FBS)
(PAN Biotech, P30-3306) (38).
RPMI 1640 + 25mM HEPES (Gibco, 11550496) containing
2 mmol/L L-glutamine and 10% heat-inactivated FBS and drugs
were pre-equilibrated in normoxia or hypoxia (0.8% O2, 5%
CO2, 70% humidity at 37
◦C, in a Baker-Ruskinn Sci-Tive UM-
027) for 24 h prior to the experiment (39). Cells were treated
in duplicate or triplicate wells with 100µg/ml LPS (InvivoGen,
tlrl-b5lps), DMSO (Sigma-Aldrich, D8418), or 15mM COX-2
inhibitor (NS398) (Cayman Chemical, 70590) and incubated for
18 h. For normoxic controls, cells were treated identically within
a class-2 tissue culture hood and transferred to a normoxic
tissue-culture incubator.
Cell supernatants were collected following 18 h incubation
and were assayed in triplicate using a human TNF ELISA MAX
(Biolegend, 430204).
Statistical Analysis
All data were analyzed (Prism 7.0, GraphPad Software) using
unpaired, two-tailed t-tests for comparisons between two groups
and ANOVA (with Bonferonni post-test adjustment) for other
data. P-values shown are: ∗P < 0.05, ∗∗P < 0.01, and
∗∗∗P < 0.001.
RESULTS
Hypoxia and Hif-1α Stabilization
Upregulate tnfa:GFP Expression in vivo
Tumor necrosis factor (TNF) is a central regulator of
macrophage pro-inflammatory phenotypes during homeostasis,
inflammation, and infection. Here, we use two transgenic
zebrafish lines that express GFP under the control of a tnfa
promoter region; TgBAC(tnfa:GFP)pd1028 and Tg(tnfa:eGFP-
F)ump5Tg (18, 20). The TgBAC(tnfa:GFP)pd1028 is a BAC
(bacterial artificial chromosome) transgenic line that contains
50 kb of promoter region (18). The Tg(tnfa:eGFP-F)ump5Tg
line has a smaller promoter region (3.8 kb) than the BAC line
(20) and has previously been demonstrated to be upregulated
in macrophages after tailfin injury in a zebrafish model (20).
Here, we demonstrate that injury-induced upregulation of
macrophage tnfa:GFP is also found in the BAC transgenic
line at 16 h post-wound (hpw), shown in double transgenic
TgBAC(tnfa:GFP)pd1028; Tg(mpeg1:mCherryCAAX)sh378
larvae (Figure 1A).
TNF has been implicated in many bacterial infections,
however the cell types involved have been difficult to observe
in vivo. To investigate this we used a well-characterized
zebrafish infection model, the M. marinum (Mm) model of
tuberculosis infection (40). We used the tnfa BAC promoter
Frontiers in Immunology | www.frontiersin.org 4 September 2019 | Volume 10 | Article 2321
Lewis and Elks Hypoxia Induces Macrophage tnfa via Cyclooxygenase
FIGURE 2 | Hif-1α-activated tnfa is cyclooxygenase dependent. (A) Confocal micrographs of 2 dpf caudal vein region of larvae in the TgBAC(tnfa:GFP)pd1028 line.
Phenol red (PR) and dominant active Hif-1α (DA1) injected larvae were treated with DMSO, SC560 (Cox-1 inhibitor), and NS398 (Cox-2 inhibitor). Dotted lines indicate
the yolk extension of the larvae where there is non-specific fluorescence. (B) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (A). Mean ± SEM, n = 36
cells from six embryos representative of three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with
Bonferonni post-test adjustment. (C) Confocal micrographs of 2 dpf caudal vein region of larvae in the TgBAC(tnfa:GFP)pd1028 line. DMSO and FG4592 treated
(Continued)
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FIGURE 2 | larvae were co-treated with DMSO, SC560 (Cox-1 inhibitor), and NS398 (Cox-2 inhibitor). Dotted lines indicate the yolk extension of the larvae where
there is non-specific fluorescence. (D) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (C). Mean ± SEM, n = 48 cells from eight embryos
representative of three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment. (E) TNF ELISA of human monocyte derived macrophages treated with LPS and incubated in normoxia or 0.8% hypoxia with or without treatment with
NS398. LPS negative controls were performed but TNF produced in these groups was below detectable levels. Mean ± SEM, n = 5–8 biological repeats from 3 to 4
donors. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment. (F) Schematic of the arachidonic
pathway indicating that stabilizing Hif-1α upregulates tnfa, an effect that is blocked using the Cox1/2 inhibitors SC560/NS398.
GFP line to establish the transcriptional regulation of tnfa
during pre- and early- larval Mm granuloma formation stages.
tnfa:GFP expression was induced in larvae following Mm
infection before granuloma onset (at 1 day post-infection,
dpi), and during granuloma formation (at 4 dpi) (Figure 1B).
tnfa:GFP expression was predominantly found in macrophages,
shown by co-localization of fluorescence with mpeg-1:mCherry
expressing macrophages (Figure 1C). Macrophage expression
was confirmed using the other tnfa promoter driven line,
Tg(tnfa:eGFP-F)ump5Tg; Tg(mpeg1:mCherry-F)ump2Tg
(Figure S1). Our data demonstrate that injury and Mm
induced tnfa expression occurs in macrophages as part of an
early response.
Hypoxia and Hif-1α stabilization are key features of
diseased tissue microenvironments that can trigger macrophage
pro-inflammatory responses. We first tested whether Hif-
1α promotes tnfa in vivo, by stabilizing Hif-1α genetically
in the tnfa:GFP BAC transgenic line (18, 20). Dominant
active (DA) Hif-1α RNA (23) resulted in upregulation of
macrophage tnfa:GFP expression (Figures 1D–F) indicating a
shift of macrophage phenotype toward a pro-inflammatory
response. Dominant negative (DN) Hif-1α caused no change in
tnfa:GFP expression (Figures 1E,F).
To ensure that endogenous levels of Hif-1α could trigger a tnfa
response, Hif-α was stabilized in embryos pharmacologically.
Treatment with the well-described hypoxia mimetic DMOG
(dimethyloxaloylglycine, a pan-hydroxylase inhibitor that
stabilizes endogenous Hif-1α via inactivation of regulatory
prolyl hydroxylase enzymes) alongside newer hydroxylase
inhibitors with reportedly greater prolyl hydroxylase selectively
than DMOG, JNJ-42041935, and FG4592 were tested in
the Tg(phd3:GFP)i144 hypoxia reporter zebrafish. phd3 is a
Hif-1α transcriptional target that is highly upregulated after
hypoxia/Hif-1α stabilization (22). Treatment with all the
hydroxylase inhibitors increased phd3:GFP levels compared
to DMSO controls demonstrating stabilization of the Hif-α
pathway (Figure S2) with FG4592 treatment leading to the
highest phd3:GFP levels (23, 30, 31, 37). FG4592 (Figure 1G),
DMOG (Figure S3A), and JNJ-42041935 (Figure S3B) treatment
upregulated tnfa:GFP expression compared to a DMSO solvent
control, phenocopying the DA Hif-1α response. tnfa:GFP
induced by hydroxylase inhibition could be blocked using
dominant negative (DN) Hif-1α, both in the case of FG4592
(Figures 1H,I) and DMOG (Figure S4), demonstrating that
hydroxylase inhibitors are acting via Hif-1α to induce tnfa:GFP.
Finally, we subjected the tnfa:GFP line to physiological
hypoxia (5% oxygen for 6 h at 32 hpf) and looked for GFP
expression at 48 hpf. This level of hypoxia was sufficient to
turn on phd3:GFP expression in Tg(phd3:GFP)i144 hypoxia
reporter zebrafish (Figure S5) (37). Hypoxia induced tnfa:GFP
expression, compared to normoxic controls at 48 hpf, to a similar
level as that observed with genetic or pharmacological Hif-1α
stabilization (Figure 1J).
Together, these data indicate that tnfa expression is induced in
macrophages in response to hypoxia and Hif-1α, a response that
is targetable by pharmacological agents and has the potential to
manipulate macrophage responses during disease.
Hif-1α Dependent tnfa:GFP Transcription
Requires Cyclooxygenase
Eicosanoids are lipid signaling molecules and can be produced
by macrophages as part of a pro-inflammatory response (9, 10).
We tested whether cyclooxygenase inhibition affected Hif-1α-
mediated macrophage tnfa:GFP expression, using Cox-1 and
Cox-2 inhibitors (SC560 and NS398, respectively) (32). First,
we showed that neither SC560 nor NS398 caused increased
Hif-α transcriptional activity, using the Tg(phd3:GFP)i144
hypoxia reporter zebrafish (Figure S6). In the absence of Hif-
1α stabilization tnfa:GFP was not altered by SC560 or NS398
compared to DMSO treated negative controls (Figures 2A,B).
Strikingly, the DA Hif-1α-induced tnfa:GFP expression was
reduced to basal levels by both SC560 and NS398 (Figures 2A,B).
These findings were replicated using the hydroxylase inhibitors
FG4592 (Figures 2C,D) and DMOG with NS398 (Figure S7),
(N.B. DMOG with SC560 caused toxicity and developmental
delay therefore data is not shown for this group). The production
of an unrelated Hif-1α target gene phd-3 by hydroxylase
inhibitors, shown in the Tg(phd3:GFP)i144 transgenic line, was
not altered by SC560 or NS398 treatment, demonstrating that
Hif-1α transcriptional potential is not affected by cyclooxygenase
inhibition (Figure S8).
We tested whether HIF-1α stabilization induced TNF in
human monocyte derived macrophages (hMDMs). We found
that human monocyte derived macrophages produced higher
levels of TNF protein in hypoxia (0.8% oxygen) than those in
normoxia, measured by an anti-human TNF ELISA (Figure 2E).
Furthermore, treatment with the COX-2 inhibitor, NS398,
reduced this hypoxia-induced TNF to equivalent levels found
in normoxia (Figure 2E). This was replicated when HIF-1α
was stabilized in hMDMs using the hypoxia mimetic FG4592
(Figure S9). These data indicate that a HIF/COX/TNF axis is
found in zebrafish and human macrophages, and could be a
druggable target in disease situations (Figure 2F).
We have previously shown that DA Hif-1α induces the
expression of another important pro-inflammatory cytokine, il-
1β, shown by an il-1β:GFP transgenic line (Figure S10A) (37).
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FIGURE 3 | Injury and infection induced tnfa:GFP is cyclooxygenase independent. (A) Confocal micrographs of the TgBAC(tnfα:GFP)pd1028 line at 3 days
post-fertilization larvae with or without tailfin wound (induced 16 h previously) in phenol red (PR) or dominant negative (DN) Hif-1α embryos. The dotted line indicates
the border of the tailfin wound. (B) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (A). Mean ± SEM, n = 60 cells from 10 embryos accumulated from
(Continued)
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FIGURE 3 | three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment.
(C) Confocal micrographs of 1 dpi caudal vein region of larvae in the TgBAC(tnfa:GFP)pd1028 line. Phenol red (PR) and dominant negative Hif-1α (DN1) injected
larvae were infected with Mm Crimson or PVP controls. (D) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (C). Mean ± SEM, n = 30 cells from five
embryos accumulated from two independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment. (E) Confocal micrographs of the TgBAC(tnfα:GFP)pd1028 line at 3 days post fertilization larvae with or without tailfin wound (induced 16 h previously) in
phenol red (PR) or dominant active Hif-1α embryos. Embryos were treated with DMSO or NS398 (Cox-2 inhibitor). (F) Corrected fluorescence intensity levels of
tnfa:GFP in larvae in (E). Mean ± SEM, n = 24 (in not wounded) or n = 36 (in wounded) cells from six embryos accumulated from two independent experiments. n.b.
Not-wounded fish had fewer macrophages at the tailfin site. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment. (G) Confocal micrographs of 1 dpi caudal vein region of Mm Crimson infected larvae in the TgBAC(tnfa:GFP)pd1028 line. Phenol red (PR) and dominant
active Hif-1α (DA1) injected larvae were treated with DMSO, SC560 (Cox-1 inhibitor), and NS398 (Cox-2 inhibitor) and infected with Mm Crimson. (H) Corrected
fluorescence intensity levels of tnfa:GFP in larvae in (G). Mean ± SEM, n = 36 cells from six embryos representative of three independent experiments. P-values
shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment.
Cox-1 inhibition by SC560 did not abrogate Hif-1α-induced
il-1β:GFP, while Cox-2 inhibition with NS398 caused a small
decrease that did not reach basal levels (Figures S10B,C). These
data indicate that Hif-1α-induced tnfa expression is caused
by a product of the cyclooxygenase arm of the arachidonic
acid pathway via a novel macrophage HIF/COX/TNF axis,
while Hif-1α-induced il-1β does not fully act via this pathway
suggestive of complex regulation of inflammatory cytokines by
Hif-1α stabilization.
We next tested whether injury- and infection-induced
tnfa are Hif-1α and cyclooxygenase dependent processes.
Induction of tnfa:GFP expression after injury was not blocked
by dominant negative Hif-1α (Figures 3A,B), and this was
also the case for Mm infection-induced tnfa:GFP expression
(Figures 3C,D). Similarly, neither genetic nor pharmacological
Hif-1α stabilization were additive to the tnfa:GFP expression
caused by either injury (Figures 3E,F) or Mm infection
(Figures 3G,H; (Figures S11A,B). These data indicate that
the early tnfa response of injury and Mm infection do not
require active Hif-1α. Macrophage tnfa:GFP expression induced
after injury was not abrogated by cyclooxygenase inhibition using
NS398 (Figures 3E,F). Similarly, cyclooxygenase inhibition using
either SC560 or NS398 did not alter the expression of Mm-
induced tnfa:GFP (Figures 3G,H). SC560 and NS398 mediated
inhibition of Hif-1α-induced tnfa expression did not diminish
the host-protective effect of DA Hif-1α (Figures S12A–C) nor
DMOG treated larvae (Figures S12D–F), suggesting that the
presence of Mm induced tnfa is sufficient for protection. Our
data indicate that Hif-1α-induced macrophage tnfa expression
via cyclooxygenase differs fromDAMP- (injury) or PAMP- (Mm)
induced tnfamechanisms.
Blocking Cyclooxygenase Independent
Arachidonic Acid Pathways Do Not
Abrogate Hif-1α Upregulation of tnfa:GFP
To investigate whether the effect of the cyclooxygenase inhibitors
on tnfa was specific to the prostaglandin path of arachidonic
acid signaling, we targeted the lipoxin and leukotriene producing
arms using the 15-Lipoxygenase inhibitor PD146176 and
leukotriene B4 receptor antagonists (Figure 4A) (33, 34). The
15-Lipoxygenase inhibitor PD146176 did not block the tnfa:GFP
induced by DA Hif-1α (Figures 4B,C). Furthermore, PD147176
increased tnfa:GFP expression on its own in the absence
of infection, although not to the same extent as DA Hif-
α (Figures 4B,C). PD146176 also did not affect tnfa:GFP
expression after Mm infection (Figures 4B,C), nor did it block
the protective effect of DA Hif-1α. Treatment with PD146176
was sufficient to decrease Mm burden, but not to the same
extent as DA Hif-1α (Figure 4D). Leukotriene B4 inhibition,
using the BLTR1/2 antagonists U75302 and LY255283, did
not increase tnfa:GFP levels and also did not block DA Hif-
1α-induced tnfa:GFP (Figures 4E,F). These data indicate that
blocking components of the lipoxygenase dependent arms of the
arachidonic acid pathway does not block the Hif-1α effect on tnfa
expression and do not replicate the effects observed by blocking
the cyclooxygenase dependent arm.
Hif-1α-Induced tnfa:GFP Requires Active
Prostaglandin E2
A key family of immune regulators downstream of arachidonic
acid and cyclooxygenases are prostaglandins. The best
characterized of these as a regulator of macrophage function
is prostaglandin E2 (PGE2) (41). We tested whether PGE2
was a mediator in the HIF/COX/TNF pathway by addition
of exogenous PGE2 to DA Hif-1α larvae (35). Exogenous
PGE2 had no effect on tnfa:GFP expression in the absence of
infection (Figures 5A,B). However, PGE2 was able to rescue
the decrease in tnfa:GFP expression after inhibition of either
Cox-1 (Figure S13) or Cox-2 (Figures 5A,B) in DA Hif-1α
larvae. Furthermore, addition of PGE2 alone was sufficient
to increase the DA Hif-1α-induced tnfa:GFP expression
(Figures 4A,B). These tnfa:GFP activating effects were not
observed by addition of exogenous 15-keto prostaglandin
E2, an immunologically inactive degradation product of
PGE2 (Figures 5C,D) (35, 42, 43). These data indicate that
Hif-1α-induced tnfa:GFP requires active prostaglandin E2.
PGE2 signals via prostanoid receptors. In human and
zebrafish there are four different receptors, EP1-4 (44). Of these,
EP4 is the best characterized in immune cells and is expressed
on human macrophages. When EP4 is blocked, macrophage pro-
inflammatory cytokine release is decreased (45). We therefore
tested a previously published EP4 antagonist AH23848 (36).
We first demonstrated that AH23848 did not activate Hif-
1α transcription using the Tg(phd3:GFP) hypoxia reporter
line (Figure S6). The increased level of phd3:GFP induced
by hydroxylase inhibitors was also not altered by AH23484
treatment, demonstrating that Hif-1α transcriptional potential is
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FIGURE 4 | Blocking 15-lipoxygenase or leukotriene B4 receptors does not abrogate DA-Hif-1α-upregulation of tnfa:GFP. (A) Schematic of the arachidonic pathway
indicating where the inhibitors act. (B) Confocal micrographs of 1 dpi caudal vein region of Mm mCrimson and PVP infected larvae in the TgBAC(tnfa:GFP)pd1028
line. Phenol red (PR) and dominant active Hif-1α (DA1) injected larvae were treated with DMSO or PD146176 (15-Lipoxygenase inhibitor). Dotted lines indicate the yolk
extension of the larvae where there is non-specific fluorescence. (C) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (B). Mean ± SEM, n = 42 cells from
seven embryos accumulated from three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni
post-test adjustment. (D) Bacterial burden at 4 dpi after injection of DA Hif-1α (DA1) and 24 h of the 15-lipoxygenase inhibitor PD146176, using DMSO as a negative
(Continued)
Frontiers in Immunology | www.frontiersin.org 9 September 2019 | Volume 10 | Article 2321
Lewis and Elks Hypoxia Induces Macrophage tnfa via Cyclooxygenase
FIGURE 4 | solvent control. Data shown are mean ± SEM, n = 48–50 as accumulated from three independent experiments. P-values shown are: *P < 0.05, **P <
0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment. (E) Confocal micrographs of 1 dpi caudal vein region of Mm mCrimson and PVP
infected larvae in the TgBAC(tnfa:GFP)pd1028 line. Phenol red (PR) and dominant active Hif-1α (DA1) injected larvae were treated with DMSO or U75302/LY255283
(BLTR1/2 inhibitors). (F) Corrected fluorescence intensity levels of tnfa:GFP confocal z-stacks in uninfected larvae (PVP, empty bars) and infected larvae (Mm, filled
bars) at 1 dpi of data shown in (E) after treatment with DMSO or U75302/LY255283 (BLTR1/2 inhibitors). Data shown are mean ± SEM, n = 30 cells from five
embryos accumulated from two independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment.
not affected by EP4 inhibition (Figure S8). Addition of AH23848
abrogated dominant active Hif-1α-induced tnfa:GFP, indicating
that Hif-1α stabilization acts through PGE2 signaling via EP4 to
upregulate Tnfa expression (Figures 5E,F).
DISCUSSION
Control of macrophage function during homeostasis and
disease are critical for maintaining healthy tissues and must
integrate changes in the local microenvironment with cytokine
signaling. Understanding of the signaling pathways that link
microenvironment with macrophage phenotypic outcomes may
identify novel therapeutic avenues for control of macrophages
during disease.
Here, we show that a disease relevant microenvironmental
cue, hypoxia signaling via Hif-1α, upregulates macrophage tnfa
expression in a cyclooxygenase dependent. TNF upregulation
by hypoxia has been previously demonstrated in a range
of mammalian cells, both directly, through HIF responsive
elements (HREs) in its promotor region, and indirectly (46–
49). Here, we addressed hypoxia-induced tnfa levels using
promoter driven GFP expression in two zebrafish transgenic
lines as a proxy for endogenous tnfa expression (18, 20).
Changes in endogenous tnfa expression on a wholebody-level
after Hif-1α stabilization were not observable by qPCR (data
not shown), presumably because the changes in transcription at
the macrophage level are too small to be detected using these
methods due to macrophages representing a small proportion
of the zebrafish larvae, a challenge that was previously reported
in wholebody detection of another pro-inflammatory cytokine,
il-1β (37). These promoter driven tnfa transgenic lines have
therefore opened up opportunities to study tnfa induction
in situ in the in vivo zebrafish. We observed increased
tnfa expression with stabilized Hif-1α, demonstrating that
hypoxia signaling alone can lead to a change of macrophage
phenotype, consistent with our previous observations with
il-1β expression, suggestive of a pro-inflammatory response
(37). Our findings are also in line with HIF-1α stabilization
being important for the production of TNF and other pro-
inflammatory molecules, such as nitric oxide (NO), leading
to host-protective effects against group A Streptococcus in in
vivo murine models (50). Not only could tnfa activation be
achieved by genetic stabilization of Hif-1α, but also using hypoxia
mimetics (hydroxylase inhibitors) and physiological hypoxia,
that stabilize endogenous Hif-1α. These findings indicate that the
Hif-1α-Tnfa axis is targetable by pharmaceuticals and could be
druggable during disease.
A similar tnfa induction was induced by infection and
inflammation in our in vivo zebrafish models. It has been
widely demonstrated that Tnfa is required for control of early
Mm infection, with perturbation of Tnfa signaling leading to
high infectious burdens (51). While Hif-1α-induced tnfa was
downregulated by cyclooxygenase inhibition, it was notable
that the high level of tnfa expression after inflammation
or infection was not affected by cyclooxygenase inhibition.
These findings are consistent with the novel HIF/COX/TNF
macrophage axis being independent of infection/inflammation-
induced macrophage Tnfa. Mm-induced Tnfa is widely
reported as being toll-like receptor (TLR) mediated, and our
data indicate that Mm-induced levels of Tnfa are sufficient
for control of bacteria in the presence of stabilized Hif-
1α (28, 52). In the absence of the TLR adapter protein
MyD88, bacterial induction of Tnfa is lost, demonstrating
the central role of TLR pathways in post-infection Tnfa
induction (28, 52–54). The best characterized exogenous
TLR signal, LPS via TLR4, can induce Tnfa production via
activation of the central pro-inflammatory regulator NFκB
(54, 55). As cyclooxygenase inhibition did not alter either
inflammation or infection driven tnfa it suggests that these
complex damage/infection driven mechanisms of Tnfa induction
are not dependent on the HIF/COX/TNF pathway. Our
data demonstrate that Hif-1α stabilization can stimulate a
macrophage tnfa producing response in the absence of a
TLR stimulus, which may have important implications in
sterile diseased tissue and infers an alternative macrophage
tuning mechanism.
Hypoxic regulation of TNF via COX has previously been
demonstrated inmammalian osteoblasts, however, little is known
about this interaction (14). Here, we demonstrate that Hif-1α
upregulation of macrophage tnfa is likely to be via the production
of PGE2 signaling via the EP4 receptor. PGE2 is an inflammatory
mediator that is known to affect macrophage polarization states
during infection, and synergises with cytokines to amplify pro-
inflammatory responses (41, 56). The degradation metabolite
15-keto-PGE2 did not rescue the loss of tnfa expression after
cyclooxygenase inhibition, consistent with previous reports
that 15-keto-PGE2 is unable to bind the prostaglandin E2
EP receptors, thus demonstrating a requirement for active
PGE2 (57).
Here, we demonstrate that a macrophage HIF/COX/TNF
pathway is found in human monocyte derived macrophages,
indicating that this pathway may have conserved roles in
macrophage homeostasis and disease, and opening up
possibilities for pharmaceutical intervention to promote
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FIGURE 5 | Hif-1α-induced tnfa:GFP requires active prostaglandin E2. (A) Confocal micrographs of 1 dpi caudal vein region in the TgBAC(tnfa:GFP)pd1028 line.
Phenol red (PR) and dominant active Hif-1α (DA1) injected larvae were treated with DMSO or NS398 (Cox-2 inhibitor) in the presence or absence of endogenous
prostaglandin E2 (PGE2). All larvae are PVP injected. (B) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (A). Mean ± SEM, n = 54 cells from nine
embryos accumulated from three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment. (C) Confocal micrographs of 1 dpi caudal vein region in the TgBAC(tnfa:GFP)pd1028 transgenic line. Phenol red (PR) and dominant active Hif-1α (DA1)
injected larvae were treated with DMSO or NS398 (Cox-2 inhibitor) in the presence or absence of endogenous 15-keto prostaglandin E2 (15K). All larvae are PVP
injected. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test adjustment. (D) Corrected fluorescence intensity
levels of tnfa:GFP in larvae in (C). Mean ± SEM, n = 24 cells from four embryos accumulated from two independent experiments. (E) Confocal micrographs of 1 dpi
caudal vein region in the TgBAC(tnfa:GFP)pd1028 transgenic line. Phenol red (PR) and dominant active Hif-1α (DA1) injected larvae were treated with DMSO or
AH2348 (EP4 inhibitor). All larvae are PVP injected. (F) Corrected fluorescence intensity levels of tnfa:GFP in larvae in (E). Mean ± SEM, n = 72 cells from 12 embryos
accumulated from three independent experiments. P-values shown are: *P < 0.05, **P < 0.01, and ***P < 0.001, two way ANOVA with Bonferonni post-test
adjustment.
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proinflammatory macrophage phenotypes in human disease.
Our findings in human MDMs indicate that the HIF/COX/TNF
pathway may, at least in part, be cell-autonomous to
macrophages, however, this was not tested in vivo where
it is likely that contributing signals from other celltypes,
for example endothelial cells, may play important roles in
macrophage phenotype outcomes (58).
Although the effect of the HIF/COX/TNF axis in early Mm
infection was negligible, this pathway is likely to have important
roles in other disease situations. Mycobacterial infection, along
with many other bacterial pathogens, stimulates early TNF
production, however some pathogens remain undetected by
macrophages during early disease. An example of this is in
Lyme disease, caused by Lyme borreliosis, where early low
TNF production is associated with worse disease outcomes
(59). Multiple infectious/inflammatory disease pathologies have
hypoxia as a feature of the tissue microenvironment, concurrent
with the presence of macrophages. For example, Hif-1αmediated
TNF activation may be pertinent in later TB infection situations
where granulomas have stabilized Hif-1α due to necrotic
and hypoxic centers (60, 61). Hypoxia is a key hallmark
of cancers with high levels of HIF-1α widely found in
those that produce large tumors where the center is hypoxic
(62). These tumors can also produce cyclooxygenase/PGE2,
where these important immunomodulatory signals are required
for cellular adaption to the tumor microenvironment (63).
Macrophages play central roles in cancer-inflammation that
could be exploited utilizing pharmaceutical control of this
novel HIF/COX/TNF mechanism. Further investigation of
the HIF/COX/TNF axis in models where hypoxia is a key
hallmark of disease pathology is required to uncover the
full therapeutic relevance of this potentially important novel
macrophage pathway.
In conclusion, we have identified a novel mechanism for
macrophage tnfa production via Hif-1α and cyclooxygenase
that is found in zebrafish and humans. Importantly, this axis
links a commonly found microenvironmental cue, hypoxia, to
a macrophage cytokine, TNF. We provide strong evidence to
show that this response acts via the cyclooxygenase/PGE2 arm
of the arachidonic pathway. Due to the central roles of these
modulators in disease microenvironments we anticipate
that this HIF/COX/TNF pathway may have important
implications in conditions such as inflammation, infection
and cancer.
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